Editor's note - Express Pharma

Taking India beyond ‘Pharmacy of the World’

Will a limited vaccine waiver limit future options?

Still tripping on TRIPS

Filling the gaps in India’s pharma manufacturing supply chain

Why we need an Aatmanirbhar booster strategy

With Omicron, the SARS-CoV-2 virus ups the ante

The Covaxin-WHO EUL saga

Biocon Biologics-SII alliance should balance business and public health

Is India’s pharma sector being penalised for its success?

Not independent, but more inter-dependent than ever before